Accustem Sciences Inc. (ACUT)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Breakdown | 2022 | 2021 |
|---|---|---|
| Operating Cash Flow | -1.8 Million | - |
| Net Income | -3.74 Million | - |
| Depreciation & Amortization | 3321.00 | - |
| Deferred income taxes | - | - |
| Stock-based compensation | 133.88 Thousand | - |
| Change in working capital | -1.8 Million | - |
| Other non-cash items | 3.6 Million | - |
| Investing Cash Flow | -10.99 Thousand | - |
| Investments in PPE | - | - |
| Acquisitions | - | - |
| Investment purchases | - | - |
| Sales/Maturities of investments | - | - |
| Other Investing Activities | -10.99 Thousand | - |
| Financing Cash Flow | 2.55 Million | - |
| Debt repayment | - | - |
| Dividends payments | - | - |
| Common Stock Repurchased | - | - |
| Common Stock Issuance | 2.67 Million | - |
| Other Financing Activities | -124.91 Thousand | - |
| Accounts receivables | - | - |
| Accounts payables | -76.84 Thousand | - |
| Inventory | - | - |
| Other working capital | -1.72 Million | - |
| Cash at beginning of period | - | - |
| Cash at end of period | 733.97 Thousand | - |
| Capital Expenditure | - | - |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | 733.97 Thousand | - |
| Free Cash Flow | -1.8 Million | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | -833.34 Thousand | -1.87 Million | -3.74 Million | -899.12 Thousand |
| Depreciation & Amortization | - | - | 908.00 | -676.99 Million | 3321.00 | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 26.2 Thousand | -17.03 Billion | 133.88 Thousand | - |
| Change in working capital | - | - | -4759.00 | -490.72 Thousand | -1.8 Million | 763.43 Million |
| Other non-cash items | - | - | 364.89 Thousand | 17.71 Billion | 3.6 Million | 899.12 Thousand |
| Investing Cash Flow | - | - | -8203.00 | - | -10.99 Thousand | 10.98 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -8203.00 | - | -10.99 Thousand | 10.98 Million |
| Financing Cash Flow | 350 Thousand | 350 Thousand | -107.25 Thousand | -107.25 Thousand | 2.55 Million | -2.75 Billion |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 350 Thousand | 350 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | -2675.93 Billion | 2.67 Million | - |
| Other Financing Activities | -350 Thousand | -350 Thousand | -107.25 Thousand | 2675.93 Billion | -124.91 Thousand | -2.75 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | -4759.00 | 9.71 Billion | -76.84 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 4759.00 | -9.71 Billion | -1.72 Million | - |
| Cash at beginning of period | - | - | 3.25 Million | 1.33 Million | - | 1.98 Billion |
| Cash at end of period | 350 Thousand | 350 Thousand | 3.24 Million | 733.97 Thousand | 733.97 Thousand | 1.33 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 553.34 Thousand | - | - | - |
| Net cash flow / Change in cash | 350 Thousand | 350 Thousand | -8203.00 | -597.98 Thousand | 733.97 Thousand | -1.98 Billion |
| Free Cash Flow | - | - | -446.09 Thousand | -490.72 Thousand | -1.8 Million | 763.43 Million |
ARS
301176
000039
EFSG
601991
336260